Navigation Links
Beyond DTC: Pharma Industry Faces New Challenges, Competition, Strategies for Market Dominance
Date:1/15/2008

NEW YORK, Jan. 15 /PRNewswire/ -- As drastic cutbacks at major pharmaceuticals continue, competition soars from generics and challenge blockbuster drug teams. Social networks have entered the zone of physician and patient encounters. Advertising expenditures are being scrutinized for ROI. Product recalls and drug safety warnings pose new issues and responsibilities on drug marketers. Yet new marketing opportunities have opened up with the growth of multicultural segments, new technologies, media channels and sales force optimization tools.

This year's 2nd Annual Pharmaceutical Sales & Marketing Executive Congress, scheduled for March 31 - April 1, 2008 in Bethesda, Maryland brings together an impressive line-up of experts and industry leaders who will outline trends, case studies, and best-practices required to reformulate pharmaceutical marketing and sales strategies in the light of the new rules of engagement in this industry. Speaking faculty includes:

-- Hon. Gene Green (D-TX), Member, Health Subcommittee - Energy & Commerce

Committee, U. S. House of Representatives

-- Paul J. Savidge, VP, Global Labeling & Compliance, Bristol-Myers Squibb

-- Liliana A. Gil, Worldwide Director of Marketing Services & Hispanic

Strategy Lead, Johnson & Johnson

-- Ellen Shapiro, Director, Division of Communications, Center for Drug

Evaluation and Research (CDER), FDA

-- David Lampinski, Associate Director, Commercial Analytics, Sepracor

Inc.

-- Jeannie Miller, Managed Markets, Jazz Pharmaceuticals

-- Glenn Byrd, VP, Regulatory Affairs, MedImmune

-- Chris Bogan, CEO, Best Practices LLC

-- John Mack, Publisher, Pharma Marketing News

-- Robin L. Winter-Sperry, M.D., President & CEO, Scientific Advantage

-- Nayan Shah M.D., Associate Professor of Medicine, Georgetown University

Medical Center

-- Hugo Stephenson, M.D., President, iGuard.Org

-- Jan Malek, Director, IDSG-Life Sciences, Cisco Systems

-- John S. Lenart, Senior Brand Director, Arestin(R), OraPharma, Inc.

-- Ilyssa Levins, President, Center for Communication Compliance and HCIL

Healthcare Consulting

-- Harry Sweeney, Chairman and CEO, Dorland Global Health Communications

Group

-- Kathy Kastner, CEO, The Health Television System

-- Ed Silverman, Founder, Pharmalot & Award-Winning Journalist, New Jersey

Star Ledger

-- Mark Bard, President, Manhattan Research

For Complete List of Speakers, Detailed Agenda, and to Register: http://www.iibig.com/P0802

Call: 212-300-2523

E-mail: rial@iibig.com


'/>"/>
SOURCE iiBIG
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
2. Out beyond the horizon
3. Out beyond the horizon
4. SAFC Pharma to Increase Viral Product Manufacturing Capacity
5. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
6. A New, Unique and Unrivalled Rat/Mouse PINP Assay for Pharmaceutical, Clinical and Academic Research Organizations.
7. Cantox Announces the Launch of Ashuren Health Sciences Pharmaceutical Division
8. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
9. ViroPharma Provides 2008 Outlook
10. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
11. Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... LONDON , May 3, 2016 ... Report Assessing Developers and Producers of Those Competitor Biologics  ... Guide to Companies, Activities and Prospects ,  ... drug companies? And what are their sales potentials? ... There you see results, trends, opportunities and revenue forecasting. ...
(Date:5/3/2016)... ... 2016 , ... According to world renowned prostate cancer surgeon, Dr. David ... had two main treatment options: surgery or radiation. Based on a patient’s goals, disease ... has enabled doctors to administer higher doses of radiation to prostate cancer ...
(Date:5/2/2016)... , May 2, 2016 Q ... its technology partner Mannin Research Inc. will be attending ... which takes place from May 1-5, 2016 in ... be meeting with its vendors and research partners. The ... development goals and other collaborative opportunities for the MAN-01 ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... StarNet Communications ... today announced the addition of three Secure Remote Desktop modules to its flagship X-Win32 ... desktops from Linux and Unix servers to the user’s PC over encrypted SSH. , ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/29/2016)... BOCA RATON, Florida , March 29, 2016 /PRNewswire/ ... ("LegacyXChange" or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect ... Synthetic DNA in ink used in a variety of ... preventing theft. Buyers of originally created collectibles from athletes ... authenticity through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):